|
Hispanics are less likely to receive or use medications for asthma,
cardiovascular disease, HIV/AIDS, mental illness, and pain, according
to a new study. These disparities in pharmaceutical treatment are
substantial and often persist even after adjustment for differences
in income, age, insurance coverage, and coexisting medical conditions.
The study, Genes, Culture, and Medicines: Bridging Gaps in Treatment
for Hispanic Americans, was co-authored by Dr. Carolina Reyes, Adolph
P. Falcón, Texas State Senator Leticia Van de Putte, and
Dr. Richard A. Levy. This study brings together for the first time
emerging research demonstrating that genetic and environmental factors
have a significant impact on the effectiveness of medicines for
Hispanic patients. It encourages physicians to tailor prescribing
for Hispanics based on age, coexisting conditions, responsiveness
to medications, and cultural perceptions of disease and treatment.
Related Articles
Download your copy
Request a copy |